Neil Johnson No Comments

News Healthcare Deals, Investments & Update Week ending Nov 17th 2025

  • Pfizer (NYSE: PFE) completes $7 Billion acquisition of Metsera (NASD: MTSR), adds MET-097i, MET-233i, and Expands Clinical Obesity Pipeline in Strategic Move for Cardiometabolic Therapeutics Leadership: The acquisition of Metsera brings new advanced obesity and cardiometabolic drug candidates, including injectable and oral therapies, accelerating innovation in this high-growth field. The deal enables rapid research, expanded expertise, and improved access to cutting-edge treatments, driven by milestone-based investments and integration of Metsera’s scientific strengths. (Link)
  • Day One Biopharmaceuticals (NASD: DAWN) to acquire Mersana Therapeutics (NASD: MRSN) in $285 Million Deal to Advance Novel ADC Emiltatug Ledadotin for Adenoid Cystic Carcinoma and expanded Oncology Portfolio: Emiltatug ledadotin (Emi-Le) targets B7-H4 in adenoid cystic carcinoma, showing promising early anti-tumour activity for patients lacking effective therapies. Day One’s acquisition plan supports rapid clinical progress, with milestones tied to regulatory and commercial outcomes, aiming to advance this innovative cancer treatment for diverse, underserved populations. (Link)
  • Galecto (NASD: GLTO) acquires Damora Therapeutics, With $285M Investment Led by Fairmount, Viking Global, Venrock, Wellington, RA Capital, Andreessen Horowitz, and Others to Advance Anti-mutCALR Therapies for Blood Cancers: The merger advances pioneering treatments for rare blood cancers, with lead antibody DMR-001 designed for greater potency and patient convenience. Expanded research and strategic guidance support rapid clinical progress, including novel therapies for acute myeloid leukaemia, improved trial designs, and broader access for affected patients. (Link)
  • Fabric acquires UCM Digital Health, adding 400 Payer and Employer Clients, to expand AI-Powered Virtual Care Nationwide: The acquisition expands Fabric’s reach, offering AI-powered virtual care for over one million new lives and enhancing efficiency for patients, payers, and providers. By integrating UCM’s clinical expertise, Fabric improves seamless care delivery, cost savings, and access, strengthening its network across health systems and employer partnerships nationwide. (Link)
  • Luma Health acquires Tonic Health from R1, Expanding Patient Intake and Follow-Up Solutions for Over 1,000 Health Systems and 100 Million Patients, for EHR-Integrated Care Innovation: The integration empowers healthcare organizations with advanced digital tools for automating patient intake, consent, and follow-up. By reducing manual tasks and streamlining data coordination, clinical teams benefit from improved workflow efficiency and better patient communication. Enhanced electronic health record connectivity ensures patients experience smoother journeys and greater access to personalized care. (Link)
  • Emergence, backed by The Pritzker Organization, acquires MedEvolve, to Transform AI-Driven Revenue Cycle Management for Healthcare Providers: MedEvolve will accelerate development of advanced automation and analytics tools to help healthcare organizations address operational inefficiencies and financial pressures. Its platform offers real-time insights for process improvement and margin recovery, supporting increased transparency, effective collections, and sustainable performance management in complex revenue cycle operations. (Link)
  • Get Well and RhythmX AI Combine Under SymphonyAI Group, to Form GW RhythmX and Advance Precision Care AI for 150 Health Systems and 85 Million Patients: The combined entity delivers integrated engagement and precision care using AI-driven data insights, streamlining patient support and clinical workflow for providers. Its enterprise-scale approach offers tailored recommendations, improved outcomes, and operational efficiency, with demonstrated success in enhancing care quality, readmission rates, and patient satisfaction across diverse healthcare settings. (Link)
  • Diversis Capital Unites Genesis Automation Healthcare, Kermit, and Meperia to Launch First End-to-End Clinical Supply Chain Platform and Highlight $1B in Global Annual Savings for 100+ Hospitals and Health Networks: The Genesis platform streamlines hospital and ambulatory center supply chains with unified digital management for inventory, charge capture, and contract pricing. Automated workflows and analytics improve data quality, reduce waste, and strengthen compliance, enabling clinicians to prioritize patient care while finance teams achieve greater transparency and control over spending. (Link)
  • Vituity Integrates Focus Medical Imaging, Expands Physician-Led Model Into Diagnostic and Interventional Radiology for Hospitals and Health Systems Nationwide: The partnership enhances clinical services with a physician-led approach, empowering medical professionals in decision-making and governance. Expanded diagnostic and interventional radiology offerings, combined with innovative teleradiology, improve operational efficiency and patient care. Hospitals and imaging centers gain more coordinated, effective, and sustainable service delivery across the healthcare continuum. (Link)
  • OneOncology and Cancer Specialists of North Florida (CSNF) Forge Partnership, via its financial sponsor TPG, to Elevate Community-Based Cancer Care and Expand Integrated Oncology Services Across North Florida: The collaboration improves oncology care for thousands of patients with access to advanced diagnostics, accelerated clinical research, and streamlined treatment delivery. Patients benefit from reduced wait times, comprehensive support, and integrated technology resources, while clinicians retain independence and expand expertise. The alliance promotes regional access to innovative therapies and superior care coordination. (Link)
  • Hyve acquires Health Grown Advisory Network (HGAN), Strengthening Healthcare Innovation Partnerships and Behavioural Health Tech Integration: The integration provides ongoing support and tailored connections for digital health innovators and organizations, enhancing marketing, strategy, and system navigation. Expanded advisory resources deepen collaboration, foster scalable partnerships, and enable health industry leaders to engage beyond traditional event cycles, increasing opportunities for impactful innovation and consumer health benefits. (Link)
  • The Lockwood Group acquires Research To Practice (RTP), via its financial sponsor Ares Management, expanding Global Oncology Education: The partnership enhances global oncology education by combining proven training formats with advanced consulting and communication expertise. Oncology professionals gain access to innovative, evidence-based resources reflecting current clinical advances. This collaboration delivers practical knowledge, supports professional growth, and helps clinicians make informed decisions to improve patient outcomes worldwide. (Link)
Neil Johnson No Comments

News Healthcare Deals, Investments & Update Week ending Nov 10th 2025

    1. BillionToOne (NASD: BLLN) raises $273 Million in U.S. IPO Led by J.P. Morgan, Piper Sandler, Jefferies, and William Blair

    The firm’s technology powers advanced prenatal and oncology diagnostics through its Unity and Northstar tests. Analysts view its IPO success as reflecting growing investor confidence in biotech innovation despite wider market uncertainty. The offering signals renewed momentum in healthcare listings, inspired by other major sector filings such as Medline’s. (Link)

    2. Sonida Senior Living (NYSE: SNDA) and CNL Healthcare Properties announce $1.8 Billion Merger Creating the Nation’s Eighth Largest Senior Housing Owner

    The merger focuses on expanding nationwide senior living operations with an emphasis on quality care and operational integrity. Both companies aim to strengthen their market position through shared values and strategic growth in key U.S. regions, while investors anticipate improved financial performance and stronger long-term value within the senior housing sector. (Link)

    3. QOL Medical to acquire Evoke Pharma (NYSE: EVOK) in All-Cash Deal Worth $11 Per Share

    The agreement merges complementary strengths in gastrointestinal innovation, expanding access to advanced treatments for diabetic gastroparesis. Both companies underscored the transaction’s strategic value in broadening therapeutic offerings and commercial reach. Supported by cash reserves, the acquisition awaits regulatory and shareholder approval, marking a step toward enhanced capabilities in GI-focused patient care. (Link)

    4. Organon sells Jada System to Laborie Medical Technologies in $465 Million Deal

    The transaction supports reorganization and debt reduction, positioning both companies for strategic growth. Laborie will expand its maternal health portfolio by incorporating the Jada device and its specialized workforce. Organon aims to redirect focus toward women’s health biopharma opportunities after recent leadership transitions, declining sales, and halted drug development initiatives. (Link)

    5. Lifecare Home Health acquires Infinity Hospice Care, via its financial sponsor Zenyth Partners, expands Hospice Services Across Nevada and Arizona

    The collaboration enhances post-acute care delivery through unified expertise in compassionate and high-acuity hospice services. Combining national infrastructure with community-based operations, both organizations aim to elevate patient experiences centered on dignity and care quality. Leadership underscores innovation and continuity as key drivers in expanding coordinated healthcare across multiple states. (Link)

    6. Optain Health acquires EyePACS to Advance AI-Driven Retinal Screening and Oculomics Innovation

    The collaboration enhances early disease detection through advanced AI imaging, expanding access to preventive care and population health programs. EyePACS’s nationwide network will integrate Optain’s automation and multilingual capabilities, improving clinical efficiency and diagnostic scalability while advancing oculomics research aimed at identifying systemic diseases through non-invasive retinal analysis. (Link)

    7. JLL Partners combines Vascular Technology Incorporated and Parks Medical Electronics to Build Vascular and Robotics Device Platform

    The merger unites advanced capabilities in vascular diagnostics and Doppler ultrasound technologies to enhance precision and clinical performance. By combining innovation with U.S.-based production, the partnership focuses on improving device reliability and expanding access to next-generation vascular tools that support surgical, therapeutic, and diagnostic applications worldwide. (Link)

    8. Omega Systems acquires PEAKE Technology Partners, via its financial sponsor Revelstoke Capital Partners to strengthen Healthcare Managed IT and Cybersecurity Capabilities

    The acquisition enhances healthcare IT services through advanced data security, compliance, and AI-driven clinical capabilities. By integrating expertise in electronic health records and HIPAA management, the partnership aims to boost operational performance and patient outcomes while expanding regional reach and reinforcing leadership in secure, technology-driven healthcare infrastructure nationwide. (Link)

    9. Acumed acquires TECHFIT Digital Surgery Assets to Advance Patient-Tailored Craniomaxillofacial Solutions

    The integration brings advanced digital planning and reconstruction capabilities to improve precision in surgical procedures across multiple specialties. By expanding personalized, data-driven care, the company aims to advance innovation in reconstructive and orthopaedic solutions. Leadership additions and global strategy alignment will support broader adoption of patient-tailored surgical technologies worldwide. (Link)

    10. RadNet and DeepHealth acquire Alpha RT to Expand Remote MRI Scanning and AI Safety Capabilities

    The integration enhances imaging efficiency through AI-powered monitoring, advanced training, and resource optimization to tackle technologist shortages. By combining intelligent staffing with remote imaging technology, the partnership strengthens scalability and nationwide support. It aligns with continued investments in AI-driven diagnostics, expanding capabilities across multiple medical imaging modalities and platforms. (Link)